InterMune (ITMN)

Add to Watchlists
Create an Alert
28.29 -0.02  -0.07% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
ITMN Price Chart
View All Events

ITMN Events

Date Type Description
Feb 25 Misc InterMune, Inc. Q4 2013 Earnings Conference Call
Feb 25 Earnings InterMune, Inc. Q4 2013 Earnings Results. Estimate: -0.66.
Oct 30 Earnings Intermune to Release Third Quarter Financial Results. Estimate: -0.71.
Oct 30 Misc Q3 2013 Intermune Earnings Conference Call
Jul 24 Misc Q2 2013 Earnings Conference Call
Jul 24 Earnings Intermune to Release Second Quarter Financial Results on July 24. Estimate: -0.69.
May 30 Misc AGM Event for Intermune, Inc.
Apr 24 Misc Q1 2013 Intermune Earnings Conference Call
Apr 24 Earnings Intermune to Release First Quarter Financial Results on April 24. Estimate: -0.76.
View All Performance Charts

ITMN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). InterMune is up 216.1% over the last year vs S&P 500 Total Return up 23.54%, Biogen Idec up 42.81%, and Alexion Pharmaceuticals up 58.10%.

Get Quote for

PDF Report for ITMN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ITMN Pro Report PDF

Portfolio Strategies Featuring ITMN

Did InterMune make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ITMN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

InterMune, Inc. is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases. It engages in therapies for the treatment of idiopathic pulmonary fibrosis, which is a lung disease. The firm's research programs are focuses on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in Brisbane, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ITMN 28.29 -0.02 -0.07% 2.538B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.